The guidance from NICE recommends the use of Altuvoct in England and Wales as a treatment option for people with severe ...

Columnist Jennifer Lynne discusses the potential impact of CDC cuts in the Division of Blood Disorders and Public Health Genomics.

In talking with his son about past Easter egg hunts, columnist Joe MacDonald recalls a lesson on finding strength amid adversity.

World Hemophilia Day, April 17, will focus on diagnosis and treatment access for women and girls, the World Federation for ...

The gene therapy BBM-H901 (dalnacogene ponparvovec) has been approved in China for adults with moderate to severe hemophilia ...

Health Canada approved Altuviiio to treat hemophilia A in children, adolescents, and adults with the condition.

Columnist G Shellye Horowitz turns to fun hobbies while coping with chronic illness. Recent art purchases offer interesting ...

There are several types of hemophilia, a rare bleeding disorder wherein the blood fails to clot properly. Hemophilia A and B are the most common types, while hemophilia C is comparatively rare. All ...

G Shellye Horowitz, MA, PPS, has strong ties to the bleeding disorders community with six traceable generations of hemophilia A in her family. She also has hemophilia A. Her advocacy work includes an ...

The FDA has approved fitusiran, now Qfitlia, as a treatment for hemophilia A or B patients, ages 12 and older, with or without inhibitors.

Hemophilia is a rare disorder in which a person’s blood is not able to clot properly, resulting in unusually easy and prolonged bleeding. Within the blood, proteins called clotting factors normally ...